Date

Friday, 16 November 2018

Location

European Medicines Agency, Amsterdam, the Netherlands

This workshop offers the opportunity to share experience and plans to address challenges and opportunities for advancing regulatory science in the medicines research space, carrying out successful development programs and clinical studies.

It aims to reflect on initiatives in place at European and at national level, identify gaps and create synergies to collectively support new medicines and innovative healthcare solutions.

The workshop brings together academic groups already engaged in regulatory science or clinical research, the European Commission's DG Research and Innovation, European research infrastructures and regulators.

The European Medicines Agency (EMA) is co-hosting this workshop with the

 

Documents

Agenda - EU-Innovation network workshop with academia

List of participants - EU-Innovation network workshop with academia

Presentation - Session 1 - New clinical trial regulation

Presentation - Session 1 - The role of EMA in promoting innovation

Presentation - Session 1 - What is the EU Innovation Network

Presentation - Session 2 - DG RTD perspective

Presentation - Session 2 - EU funded initiatives - EU infrastructures - EATRIS

Presentation - Session 2 - EU funded initiatives - EU infrastructures - ECRIN

Presentation - Session 2 - EU funded initiatives - EU infrastructures - ELIXIR

Presentation - Session 2 - EU funded initiatives - CSA STARS

Presentation - Session 2 - EU funded initiatives - EU infrastructures - BBMRI

Presentation - Session 3 - AT - Answers to breakout sessions

Presentation - Session 3 - CZ - Answers to breakout sessions

Presentation - Session 3 - ES - Answers to breakout sessions

Presentation - Session 3 - IE - Answers to breakout sessions

Presentation - Session 3 - MT - Answers to breakout sessions

Registration

Contact point

Related content

How useful do you find this page?